Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 73.22
+1.69 (2.36%)
At close: Jul 31, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 9.63 billion as of July 31, 2026. Its market cap has increased by 16.69% in one year.
Market Cap
9.63B
Enterprise Value
9.35B
Revenue
1.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
73.22
ChartMarket Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 9.63B, an increase of 118.81%. That is a compound annual growth rate of 12.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 9.63B | 29.82% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 10.97B |
| Hualan Biological Vaccine | 10.51B |
| Staidson (Beijing) BioPharmaceuticals | 10.50B |
| Pacific Shuanglin Bio-pharmacy | 9.91B |
| GemPharmatech | 9.88B |
| Beijing Hotgen Biotech | 9.48B |
| Nanjing Vazyme Biotech | 9.01B |
| Jiangxi Fushine Pharmaceutical | 8.84B |